UBS Group AG

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1610520 ZURICH, V8

Back to BBIO Full portfolio

Position in BBIO

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$150,511,726

+$7,042,112 QoQ

Shares Held

2,026,821

+8.1% QoQ

Ownership

1.03%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 74% Shared 0% None 26%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Mar 31, 2026

CallValue

$286,903,510

CallShares

3,863,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. BBIO ranks #13 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

All Filings in BBIO

Export CSV

37 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$286,903,510	3,863,500	+90.6%	Call	Defined	2026-05-05
2026-03-31	$150,511,726	2,026,821	-47.5%	Shares	Defined	2026-05-05
2025-12-31	$295,519,115	3,863,500	+106.0%	Call	Defined	2026-01-29
2025-12-31	$143,469,614	1,875,665	-27.5%	Shares	Defined	2026-01-29
2025-09-30	$134,338,757	2,586,422	-33.1%	Shares	Defined	2025-11-13
2025-09-30	$200,670,190	3,863,500	+37.4%	Call	Defined	2025-11-13
2025-06-30	$121,443,704	2,812,499	-27.2%	Shares	Defined	2025-08-14
2025-06-30	$166,825,930	3,863,500	+75.7%	Call	Defined	2025-08-14
2025-03-31	$76,002,627	2,198,514	-43.4%	Shares	Defined	2025-05-13
2025-03-31	$134,345,934	3,886,200	+111.2%	Call	Defined	2025-05-13
2024-12-31	$50,485,618	1,839,855	-54.0%	Shares	Defined	2025-02-14
2024-12-31	$109,809,392	4,001,800	+268.2%	Call	Defined	2025-02-14
2024-09-30	$27,669,747	1,086,793	-73.6%	Shares	Defined	2024-11-14
2024-09-30	$104,622,778	4,109,300	+6.4%	Call	Defined	2024-11-14
2024-06-30	$97,862,455	3,863,500	+253.7%	Call	Defined	2024-08-14
2024-06-30	$27,668,312	1,092,314	-71.7%	Shares	Defined	2024-08-14
2024-03-31	$119,459,420	3,863,500	+251.4%	Call	Defined	2024-05-13
2024-03-31	$33,997,961	1,099,546	+11.6%	Shares	Defined	2024-05-13
2023-12-31	$39,785,038	985,510	+545.9%	Shares	Defined	2024-02-09
2023-09-30	$4,023,269	152,570	+1160.9%	Shares	Defined	2023-11-09
2023-06-30	$208,120	12,100	-92.6%	Call	Defined	2023-08-11
2023-06-30	$2,796,392	162,581	+91.9%	Shares	Defined	2023-08-11
2023-03-31	$1,404,954	84,738	-76.5%	Shares	Defined	2023-05-12
2022-12-31	$2,742,270	359,878	+3983.5%	Shares	Defined	2023-02-08
2022-09-30	$87,601	8,813	-96.0%	Shares	Defined	2022-11-10
2022-06-30	$2,007,378	221,077	-50.0%	Shares	Defined	2022-08-10
2022-03-31	$4,486,705	442,040	+10424.8%	Shares	Defined	2022-05-16
2021-12-31	$70,056	4,200	-93.5%	Put	Defined	2022-02-14
2021-12-31	$1,072,306	64,287	+1212.0%	Shares	Defined	2022-02-14
2021-12-31	$81,732	4,900	-95.7%	Call	Defined	2022-02-14
2021-09-30	$5,283,420	112,725	+415.3%	Shares	Defined	2021-11-15
2021-06-30	$1,333,499	21,875	+64.0%	Shares	Defined	2021-08-13
2021-03-31	$821,805	13,341	-30.2%	Shares	Defined	2021-05-12
2020-12-31	$1,359,480	19,118	+4.5%	Shares	Defined	2021-02-11
2020-09-30	$686,428	18,295	-5.4%	Shares	Defined	2020-11-12
2020-06-30	$630,807	19,344	+21.5%	Shares	Defined	2020-07-31
2020-03-31	$461,680	15,920	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.